Geriatric Oncology

Population aged more than 65 years are more susceptible to chronic diseases because of their reduced capacity of the immune system. With a rapidly ageing population moving the spotlight to geriatric oncology, research in this field is also rapidly progressing. Elderly people are heterogeneous and regularly barred from clinical trials. New models of care would be invaluable for older adults with cancer, encouraging joint effort, correspondence, and patient centeredness and limiting the fracture that debilitates the current provision of cancer care. The more regrettable result for elderly patients is just halfway disclosed by decreased tolerance to treatment regimens related with the expanding number and seriousness of comorbidities. The worldwide interventional radiology market is foreseen to grow with the CAGR of 6.8% during the period 2018-2023. Increasing predominance of the chronic diseases such as cancer and growing popularity of the minimally invasive technology are estimated to be the major factors that are driving the growth of the market. In addition, innovative advancement in the interventional radiology devices, increasing geriatric population and faster recovery and cost viability are additionally assessed to be the central point that are increasing the development of the market.

    Related Conference of Geriatric Oncology

    December 09-10, 2019

    International Conference on Geriatrics and Ageing

    Bangkok, Thailand

    Geriatric Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in